StandardPlus : Tailored Immune Profiling with Your Specific Marker
Customize Teiko’s 41-marker CyTOF panel for whole blood profiling with an additional antibody to track specific cell types, pathways, or targets
With StandardPlus, customers can add an additional antibody to Teiko’s Standard 41-marker whole blood panel to detect a specific marker of interest.
Customers will select a monoclonal antibody and Teiko will verify the staining of your marker of interest and its compatibility with the 41-marker Standard whole blood CyTOF Panel.
Customers will receive a marker verification report, including a 6-point titration of the selected antibody, sample and gating quality control (QC) report for each cohort of processed samples, and Base, Core, or Premier analysis and deliverables accessible through Teiko’s web application.
CLIA-Validated Whole Blood CyTOF Backbone Panel Ready for Custom Antibody Addition
Integrate your specific antibody into a robust 41-marker backbone for accurate detection of immune cell types, subsets, and protein expression
Discover immune biomarkers and features to understand dose escalation, uncover mechanisms of action, and complement pharmacodynamic assays in your clinical trials.
Add your cell type or marker of interest with our 41-marker CyTOF panel to analyze 700+ cell types and subsets. Ensure accurate frequency measurements with a coefficient of variation below 10% for all major immune cell types with the 41-marker backbone.
Total Average Coefficient of Variation:
- Intra-Run Precision: 2.18%
- Inter-Run Precision: 6.84%
- Inter-Kit Precision: 5.75%
Validated with our TokuKit – designed for simplified sample collection at clinical sites.
Up to 720+ Immune Subsets and States Analyzed
Expertly Designed Human Pan-Immune Whole Blood Panel
The TokuProfile Standard Human Pan-Immune Whole Blood panel includes:
- Markers to identify every major immune cell population and subsets
- Expression of key co-stimulatory and co-inhibitory molecules that regulate cell function
- Markers of recent activation and effector function
- Compatible with the TokuKit – Teiko’s whole blood collection kit
-
T cells
- CD3
- Total T cells
- CD4
- CD4+ T cells
- CD8a
- CD8+ T cells
- CD27
- Maturation
- CD45RA
- Naive/Memory
- CCR7 (CD197)
- Naive/Memory
- Foxp3
- Treg
- CD25
- Treg, activation
- CD127
- T cell subsets
- T-bet
- T cell subsets
- CD38
- Maturation
- HLA-DR
- Activation
- TCF1
- Stemness
- CD7
- T cell subsets
- CD56
- NKT, T cell subsets
- gdTCR
- gdT cells
- CTLA-4 (CD152)
- Checkpoint
- PD-1
- Checkpoint
- TIM-3
- Checkpoint
- TIGIT
- Checkpoint
- LAG3
- Checkpoint
- CD161
- Inhibitory Receptor
-
B cells
- CD19
- Total B cells
- CD25
- Activation
- CD27
- Naive/Memory
- CD38
- Naive/Memory
- HLA-DR
- Antigen presentation
- CD74
- Antigen presentation
-
NK cells
- CD56
- NK cell subsets
- CD16
- NK cell subsets
- CD8a
- NK cell subsets
- CD7
- NK cell subsets
- CD38
- Activation
- T-bet
- Maturation
-
Myeloid cells
- CD11b
- Monocytes, macrophages
- CD11c
- Monocytes, macrophages, DCs
- CD14
- Monocyte subsets, Macrophages
- CD16
- Monocyte subsets
- CD33
- Total myeloid
- CD123
- pDC
- PD-L1
- Checkpoint ligand
- HLA-DR
- Antigen presentation
- CD86
- Antigen presentation
- LOX-1
- PMN-MDSCs
- CD74
- Antigen presentation
-
Granulocytes
Whole blood only- CD66b
- Granulocytes
- CD11b
- Neutrophils
- CD16
- Neutrophils
- CD15
- Neutrophils
- CD123
- Basophils
- FcER1
- Basophils, Mast cells
- cKit
- Mast cells
-
General
- CD45
- Total immune cells
- KI67
- Proliferation
- CD61
- Platelets
- CD235ab
- Erythrocytes
- DNA
- Singlets
- Live/Dead
- Viability
- IgG4
- Nivo/Pembro
- Siglec-8
- Cleanup gate
CLIA Validation Data
Mass Cytometry Assay for Pan-Immune Profiling of Whole Blood Collected with TokuKit-SHFill out the form below to access our CLIA Validation plan, report, data and SOPs.